Moderna Inc. announced over the weekend that it dosed its first participants in each age cohort with its #Covid_19 #vaccine in the company’s Phase 2 study.https://t.co/GCMCXfciKp
— The Jerusalem Post (@Jerusalem_Post) May 31, 2020
Moderna: First patients dosed with COVID-19 vaccine in Phase 2 study - The Jerusalem Post https://t.co/LCaBK5fekB
— Ophir Gottlieb (@OphirGottlieb) May 31, 2020
-
"600 people are expected to take part in the study"
First patients were dosed with Moderna’s COVID-19 vaccine starting its Phase 2 trial
— Mel ? the Enforcer (@Fah_Lo_Me) May 31, 2020
They will be given another vaccination/placebo in 28 days
600 ppl are taking part in the study and will be tracked for 12 MONTHS
So how will there be a vaccine by fall?https://t.co/UlMHAL1EGY
Moderna, the leading vaccine candidate in the US, has just dosed its first patients for a phase 2 trial. Phase 3 is expected to begin in early July. https://t.co/3oVg8z8kAq
— Alicia Smith (@Alicia_Smith19) May 30, 2020
Moderna’s COVID-19 mRNA vaccine enters Phase 2 with human testing https://t.co/zStf3gFoZq
— Evan Kirstel #MasksForAll #RemoteWork (@evankirstel) May 31, 2020